Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Basal-Like Breast Carcinoma
|
9 | 0.716 | 0.240 | 20 | 56386407 | missense variant | T/C | snv | 0.85 | 0.84 | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||
Esophageal carcinoma
|
272 | 0.716 | 0.240 | 20 | 56386407 | missense variant | T/C | snv | 0.85 | 0.84 | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||
Esophageal Neoplasms
|
270 | 0.716 | 0.240 | 20 | 56386407 | missense variant | T/C | snv | 0.85 | 0.84 | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||
Invasive Ductal Breast Carcinoma
|
16 | 0.716 | 0.240 | 20 | 56386407 | missense variant | T/C | snv | 0.85 | 0.84 | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||
Lip and Oral Cavity Carcinoma
|
172 | 0.716 | 0.240 | 20 | 56386407 | missense variant | T/C | snv | 0.85 | 0.84 | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||
Malignant neoplasm of esophagus
|
214 | 0.716 | 0.240 | 20 | 56386407 | missense variant | T/C | snv | 0.85 | 0.84 | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||
Malignant neoplasm of mouth
|
184 | 0.716 | 0.240 | 20 | 56386407 | missense variant | T/C | snv | 0.85 | 0.84 | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||
Neoplasms
|
1644 | 0.716 | 0.240 | 20 | 56386407 | missense variant | T/C | snv | 0.85 | 0.84 | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||
Uterine Cancer
|
4 | 0.716 | 0.240 | 20 | 56386407 | missense variant | T/C | snv | 0.85 | 0.84 | 0.010 | 1.000 | 1 | 2007 | 2007 | ||||
Carcinoma of lung
|
1204 | 0.716 | 0.240 | 20 | 56386407 | missense variant | T/C | snv | 0.85 | 0.84 | 0.020 | 0.500 | 2 | 2007 | 2015 | ||||
Liver carcinoma
|
942 | 0.716 | 0.240 | 20 | 56386407 | missense variant | T/C | snv | 0.85 | 0.84 | 0.020 | 0.500 | 2 | 2017 | 2018 | ||||
Malignant neoplasm of lung
|
1142 | 0.716 | 0.240 | 20 | 56386407 | missense variant | T/C | snv | 0.85 | 0.84 | 0.020 | 0.500 | 2 | 2007 | 2015 | ||||
Primary malignant neoplasm of lung
|
981 | 0.716 | 0.240 | 20 | 56386407 | missense variant | T/C | snv | 0.85 | 0.84 | 0.020 | 0.500 | 2 | 2007 | 2015 | ||||
Malignant neoplasm of stomach
|
615 | 0.716 | 0.240 | 20 | 56386407 | missense variant | T/C | snv | 0.85 | 0.84 | 0.030 | 1.000 | 3 | 2006 | 2019 | ||||
Malignant Neoplasms
|
1641 | 0.716 | 0.240 | 20 | 56386407 | missense variant | T/C | snv | 0.85 | 0.84 | 0.030 | 1.000 | 3 | 2014 | 2017 | ||||
Primary malignant neoplasm
|
1374 | 0.716 | 0.240 | 20 | 56386407 | missense variant | T/C | snv | 0.85 | 0.84 | 0.030 | 1.000 | 3 | 2014 | 2017 | ||||
Stomach Carcinoma
|
652 | 0.716 | 0.240 | 20 | 56386407 | missense variant | T/C | snv | 0.85 | 0.84 | 0.030 | 1.000 | 3 | 2006 | 2019 | ||||
Breast Carcinoma
|
2793 | 0.716 | 0.240 | 20 | 56386407 | missense variant | T/C | snv | 0.85 | 0.84 | 0.060 | 0.833 | 6 | 2004 | 2017 | ||||
Malignant neoplasm of breast
|
3417 | 0.716 | 0.240 | 20 | 56386407 | missense variant | T/C | snv | 0.85 | 0.84 | 0.060 | 0.833 | 6 | 2004 | 2017 |